The Effects of Sacubitril/Valsartan on Clinical, Biochemical and Echocardiographic Parameters in Patients with Heart Failure with Reduced Ejection Fraction: The “Hemodynamic Recovery”

201933 citationsJournal Articlegold Open Access

Authors

Giuseppe Romano · Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

Giuseppe Vitale · Ospedale Buccheri la Ferla Fatebenefratelli

Laura Ajello · Fatebenefratelli Hospital

Valentina Agnese · Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

Diego Bellavia · Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

Giuseppa Caccamo · Ospedale Buccheri la Ferla Fatebenefratelli

Abstract

Sacubitril/valsartan induce "hemodynamic recovery" and, consistently with reduction in Nt-proBNP concentrations, improve NYHA class despite diuretic dose reduction.

Topics & Keywords

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Cardiac Ischemia and Reperfusion

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Medicine

Volume 8, Issue 12, pp. 2165-2165

DOI: 10.3390/jcm8122165

Field-Weighted Citation Impact: 4.02